bioRxivBioinformaticsPreprint
Benchmarking tissue- and cell type-of-origin deconvolution in cell-free transcriptomics
Alexis IoannouiD, Elias T. FrimaniD, Carsten O. DaubiD, Wendy A. BickmoreiD, Simon Cameron BiddieiD
Abstract
Plasma cell-free RNA (cfRNA) reflects tissue- and cell-type-specific activity across pathological states and is a promising biomarker for organ injury and disease. Computational deconvolution methods are widely used to infer organ and cell-type contributions to cfRNA profiles. However, most were originally developed for single-tissue bulk transcriptomes and their performance in body-wide cfRNA settings, where any tissue or cell type can contribute, remains poorly characterised. Here, we present a systematic benchmarking of tissue- and cell type-of-origin deconvolution for plasma cfRNA that considers both methodological and reference-related sources of variability under realistic cfRNA simulation settings. We evaluated seven commonly used deconvolution methods across distinct algorithmic classes and multi-organ reference configurations derived from bulk and single-cell atlases. We assessed performance using simulation frameworks that model multi-organ mixtures, technical noise, and transcript degradation. We further examined deconvolution methods across multiple previously published clinical cfRNA cohorts spanning diverse disease contexts. Across both tissue- and cell-type-level analyses, deconvolution performance was strongly influenced by both method choice and reference parameters. Tissue-of-origin inference was comparatively robust across simulated and clinical datasets, recovering disease-associated organ signals and concordance with biochemical markers. In contrast, cell type-of-origin inference showed greater variability and reduced consistency across analytical settings, leading to divergent interpretations in both simulations and published clinical cfRNA cohorts. Together, these findings demonstrate that methodological and reference-related variability are major sources of uncertainty in cfRNA deconvolution, with tissue-level inference being more robust than cell-type-level inference. Our benchmarking framework provides guidance for reference selection and comparative interpretation in cfRNA deconvolution.
- Citations
- 0
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Cell Types of Origin in the Cell Free Transcriptome in Human Health and Disease
Sevahn K. Vorperian, Mira N. Moufarrej, Stephen R. Quake·bioRxiv·May 5, 2021
- Systematic Evaluation of Cell Type Deconvolution Methods for Plasma Cell-free DNA
Tongyue Sun, Jinqi Yuan, … Yumei Li·bioRxiv·Mar 25, 2024
- Estimating the effect of tissue- and blood-derived cell reference matrices on deconvolving bulk transcriptomic datasets
Siqi Sun, Shweta Yadav, … Jing Wang·Computational and Structural Biotechnology JournalPeer-reviewed·Jan 1, 2025
- Benchmark of cellular deconvolution methods using a multi-assay reference dataset from postmortem human prefrontal cortex
Louise A. Huuki-Myers, Kelsey D. Montgomery, … Leonardo Collado‐Torres·Genome biologyPeer-reviewed·Apr 7, 2025
- Depletion-assisted multiplexed cell-free RNA sequencing reveals distinct human and microbial signatures in plasma versus extracellular vesicles
Hongke Wang, Qing Zhan, … Zhi Lü·Clinical and Translational MedicinePeer-reviewed·Jul 1, 2024
- CATD: A reproducible pipeline for selecting cell-type deconvolution methods across tissues
Anna Vathrakokoili Pournara, Zhichao Miao, … Irene Papatheodorou·Bioinformatics AdvancesPeer-reviewed·Jan 1, 2024